Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Milestone Pharmaceuticals Inc. per 2025 Jun 30 adalah -55.02 MM.
- Nilai net income untuk Milestone Pharmaceuticals Inc. per 2025 Jun 30 adalah -55.53 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -55.02 | -55.53 | |
2025-03-31 | -52.15 | -51.93 | |
2024-12-31 | -42.10 | -41.52 | |
2024-09-30 | 0.00 | -43.55 | -42.77 |
2024-06-30 | 0.00 | -49.30 | -48.41 |
2024-03-31 | 0.00 | -56.07 | -55.09 |
2023-12-31 | 1.00 | -61.10 | -59.69 |
2023-09-30 | 4.50 | -61.06 | -59.25 |
2023-06-30 | 6.00 | -60.73 | -58.73 |
2023-03-31 | 6.00 | -61.10 | -59.33 |
2022-12-31 | 5.00 | -59.64 | -58.39 |
2022-09-30 | 1.50 | -62.80 | -62.09 |
2022-06-30 | 0.00 | -62.04 | -61.76 |
2022-03-31 | 15.00 | -44.53 | -44.35 |
2021-12-31 | 15.00 | -43.07 | -42.85 |
2021-09-30 | 15.00 | -34.92 | -34.63 |
2021-06-30 | 15.00 | -32.73 | -32.39 |
2021-03-31 | -46.55 | -46.14 | |
2020-12-31 | -50.71 | -49.97 | |
2020-09-30 | -60.84 | -59.59 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.78 | -0.78 |
2024-12-31 | -0.67 | |
2024-09-30 | -0.76 | -0.76 |
2024-06-30 | -0.96 | -0.96 |
2024-03-31 | -1.23 | -1.23 |
2023-12-31 | -1.39 | |
2023-09-30 | -1.38 | -1.38 |
2023-06-30 | -1.37 | -1.37 |
2023-03-31 | -1.39 | -1.39 |
2022-12-31 | -1.38 | |
2022-09-30 | -1.47 | -1.47 |
2022-06-30 | -1.46 | -1.47 |
2022-03-31 | -1.05 | -1.05 |
2021-12-31 | -1.02 | |
2021-09-30 | -0.85 | -0.85 |
2021-06-30 | -0.86 | -0.85 |
2021-03-31 | -1.38 | -1.38 |
2020-12-31 | -1.70 | |
2020-09-30 | -2.30 | -2.30 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Milestone Pharmaceuticals Inc. per 2025 Jun 30 adalah -40.38 MM.
- Nilai cash from investing activities untuk Milestone Pharmaceuticals Inc. per 2025 Jun 30 adalah 69.34 MM.
- Nilai kas dari aktivitas pendanaan untuk Milestone Pharmaceuticals Inc. per 2025 Jun 30 adalah 0.27 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -40.38 | 69.34 | 0.27 |
2025-03-31 | -33.87 | 68.88 | -0.06 |
2024-12-31 | -28.85 | 8.28 | 32.12 |
2024-09-30 | -31.80 | 2.62 | 32.10 |
2024-06-30 | -36.94 | -14.71 | 32.33 |
2024-03-31 | -41.45 | -52.23 | 29.86 |
2023-12-31 | -46.42 | 4.76 | 47.79 |
2023-09-30 | -49.49 | -25.93 | 48.02 |
2023-06-30 | -48.90 | -32.13 | 50.38 |
2023-03-31 | -52.42 | -19.16 | 53.29 |
2022-12-31 | -52.47 | -57.12 | 3.09 |
2022-09-30 | -51.98 | -25.11 | 2.95 |
2022-06-30 | -49.80 | 14.94 | 0.30 |
2022-03-31 | -34.70 | 50.00 | 5.08 |
2021-12-31 | -33.22 | 70.00 | 5.05 |
2021-09-30 | -29.60 | 41.00 | 53.12 |
2021-06-30 | -27.55 | -6.00 | 77.91 |
2021-03-31 | -45.12 | -58.00 | 73.17 |
2020-12-31 | -50.73 | -70.00 | 73.22 |
2020-09-30 | -58.58 | -26.10 | 25.09 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -2.47.
- p/libro untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -20.98.
- p/tbv untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -20.98.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -2.47 | -20.98 | -20.98 |
2025-03-31 | 3.57 | 3.57 | |
2024-12-31 | 5.00 | 5.00 | |
2024-09-30 | -1.67 | 2.53 | 2.53 |
2024-06-30 | -1.55 | 2.14 | 2.14 |
2024-03-31 | -1.80 | 6.41 | 6.41 |
2023-12-31 | -1.20 | 2.49 | 2.49 |
2023-09-30 | -2.22 | 3.22 | 3.22 |
2023-06-30 | -2.08 | 2.29 | 2.29 |
2023-03-31 | -2.92 | 2.57 | |
2022-12-31 | 1.77 | 1.77 | |
2022-09-30 | 3.18 | 3.18 | |
2022-06-30 | -4.15 | 1.83 | 1.83 |
2022-03-31 | -4.76 | 1.81 | 1.81 |
2021-12-31 | -5.75 | 1.56 | 1.56 |
2021-09-30 | -5.25 | 1.22 | 1.22 |
2021-06-30 | 0.00 | ||
2021-03-31 | -3.56 | 1.24 | 1.24 |
2020-12-31 | -3.28 | 1.15 | 1.15 |
2020-09-30 | -2.28 | 1.33 | 1.33 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.38.
- EBIT (3 tahun) / EV untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.39.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.38 | -0.39 |
2025-03-31 | -0.55 | -0.69 |
2024-12-31 | -0.27 | -0.34 |
2024-09-30 | -0.41 | -0.47 |
2024-06-30 | -0.44 | -0.42 |
2024-03-31 | -0.42 | -0.37 |
2023-12-31 | -0.54 | -0.47 |
2023-09-30 | -0.40 | -0.35 |
2023-06-30 | -0.61 | -0.53 |
2023-03-31 | -0.36 | -0.30 |
2022-12-31 | -0.62 | -0.52 |
2022-09-30 | -0.29 | -0.25 |
2022-06-30 | -0.48 | -0.50 |
2022-03-31 | -0.48 | -0.56 |
2021-12-31 | -0.39 | -0.53 |
2021-09-30 | -0.45 | -0.64 |
2021-06-30 | ||
2021-03-31 | -0.50 | -0.49 |
2020-12-31 | -0.54 | -0.47 |
2020-09-30 | -0.67 | -0.40 |
Efektivitas Manajemen
- roa untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.58.
- roe untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -1.62.
- roic untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -1.05.
- croic untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah 0.71.
- ocroic untuk Milestone Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.68.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.58 | -1.62 | -1.05 | 0.71 | -0.68 |
2025-03-31 | -0.43 | -1.04 | -0.61 | 0.17 | -0.42 |
2024-12-31 | -0.57 | -2.55 | -0.55 | 0.04 | -0.41 |
2024-09-30 | -0.56 | -1.70 | -0.57 | -0.23 | -0.43 |
2024-06-30 | -0.50 | -1.02 | -0.60 | -0.69 | -0.45 |
2024-03-31 | -0.80 | -0.90 | -0.87 | 0.09 | -0.68 |
2023-12-31 | -0.69 | -0.77 | -0.74 | -0.34 | -0.62 |
2023-09-30 | -0.64 | -0.68 | -0.65 | -0.34 | -0.54 |
2023-06-30 | -0.65 | -0.68 | -0.65 | -0.34 | -0.54 |
2023-03-31 | -0.55 | -0.58 | -1.05 | -0.32 | -0.93 |
2022-12-31 | -0.46 | -0.49 | -0.78 | -0.93 | -0.65 |
2022-09-30 | -0.46 | -0.48 | -0.78 | -0.93 | -0.65 |
2022-06-30 | -0.30 | -0.32 | -0.71 | -0.40 | -0.57 |
2022-03-31 | -0.31 | -0.32 | -0.44 | 0.20 | -0.34 |
2021-12-31 | -0.23 | -0.24 | -0.38 | 0.37 | -0.23 |
2021-09-30 | -0.30 | -0.32 | -0.27 | 0.50 | -0.20 |
2021-06-30 | -0.35 | -0.37 | -0.23 | 0.32 | -0.20 |
2021-03-31 | -0.44 | -0.46 | -0.35 | -0.23 | -0.34 |
2020-12-31 | -0.40 | -0.43 | -0.35 | -0.33 | -0.35 |
2020-09-30 | -0.42 | -0.45 | -0.58 | -0.58 | -0.57 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | 1.00 | -59.68 | -61.10 |
2023-12-31 | 1.00 | -13.17 | -13.57 |
2023-09-30 | 1.00 | -9.79 | -10.12 |
2023-06-30 | 1.00 | -9.79 | -10.12 |
2023-03-31 | 1.00 | -9.89 | -10.18 |
2022-12-31 | 0.00 | -41.40 | -41.87 |
2022-09-30 | -41.40 | -41.87 | |
2022-06-30 | 1.00 | ||
2022-03-31 | 1.00 | -2.96 | -2.97 |
2021-12-31 | 1.11 | -2.86 | -2.87 |
2021-09-30 | 1.16 | -2.31 | -2.33 |
2021-06-30 | 1.16 | -2.16 | -2.18 |
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1408443 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |